Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden.
(2014) In Thrombosis Journal 12(1).- Abstract
- In clinical trials new oral anticoagulants (NOAC) have proved to be as effective as warfarin for thromboprophylaxis in atrial fibrillation. The aim of this study was to evaluate the efficacy and safety of these drugs in clinical practise.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/4908246
- author
- Labaf, Ashkan LU ; Carlwe, Martin and Svensson, Peter LU
- organization
- publishing date
- 2014
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Thrombosis Journal
- volume
- 12
- issue
- 1
- article number
- 29
- publisher
- BioMed Central (BMC)
- external identifiers
-
- pmid:25506268
- scopus:84924107218
- pmid:25506268
- ISSN
- 1477-9560
- DOI
- 10.1186/s12959-014-0029-6
- language
- English
- LU publication?
- yes
- id
- f888bfbe-d101-4585-9287-9c9ffc5af7bd (old id 4908246)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/25506268?dopt=Abstract
- date added to LUP
- 2016-04-01 13:26:13
- date last changed
- 2022-03-14 00:02:57
@article{f888bfbe-d101-4585-9287-9c9ffc5af7bd, abstract = {{In clinical trials new oral anticoagulants (NOAC) have proved to be as effective as warfarin for thromboprophylaxis in atrial fibrillation. The aim of this study was to evaluate the efficacy and safety of these drugs in clinical practise.}}, author = {{Labaf, Ashkan and Carlwe, Martin and Svensson, Peter}}, issn = {{1477-9560}}, language = {{eng}}, number = {{1}}, publisher = {{BioMed Central (BMC)}}, series = {{Thrombosis Journal}}, title = {{Efficacy and safety of novel oral anticoagulants in clinical practice: a report from three centers in Sweden.}}, url = {{https://lup.lub.lu.se/search/files/3369264/7851941}}, doi = {{10.1186/s12959-014-0029-6}}, volume = {{12}}, year = {{2014}}, }